Organon (OGN) Return on Equity (2020 - 2026)

Organon's Return on Equity history runs 7 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Equity fell 1.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (down 1.0% YoY), while the FY2025 annual figure was 0.0%, down 4.0% from the prior year.
• Return on Equity was 0.0% for Q1 2026 at Organon, up from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.1% in Q2 2024 to a low of 0.95% in Q1 2024.
• Historically, Return on Equity has averaged 0.06% across 5 years, with a median of 0.0% in 2026.
• The sharpest annual moves came in 2024 and 2025: Return on Equity slumped 95 bps in 2024, then surged 97 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2022, then slumped by 107135 bps to 0.03% in 2023, then soared by 158 bps to 0.02% in 2024, then sank by 87 bps to 0.0% in 2025, then soared by 32 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.